ICCR Benchmarks Pharma Responses to AIDS and Diseases of Poverty in Emerging Markets
The Interfaith Center on Corporate Responsibility report assesses 15 pharmaceutical companies, and finds all of them falling short of best practice in most areas on AIDS and neglected diseases.

White House and Interfaith Center on Corporate Responsibility Address Pediatric AIDS
Bush Administration launches a new public-private partnership on Pediatric AIDS, an area where ICCR engages pharmaceutical companies in shareowner advocacy.

Pharma and Biotech Companies Just Starting to Pass the Transparency Litmus Test
oekom research rates the social and environmental sustainability performance of 27 pharmaceutical and biotechnology companies, and finds disclosure lacking across the board.